Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies
10 de agosto de 2026 actualizado por: youssef alaa
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologies (Randomized Controlled Clinical Trial & In-Vitro Study)
The clinical study aimed to evaluate the clinical performance, color stability, and wear of indirect composite veneers produced using 3D printing and milling technologies.
Descripción general del estudio
Estado
Terminado
Descripción detallada
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
Tipo de estudio
Intervencionista
Inscripción (Actual)
14
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Alexandria, Egipto
- Faculty of dentistry, Alexandria university
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Healthy adult patients aged 18 to 45 years.
- Patients requiring veneer restorations due to discoloration, misalignment, tooth malformation or having irregular tooth shape that can be treated without full coverage.
- Patients meeting the criteria for Class I or Class II veneers according to the LeSage veneer classification system.
- Patients requiring veneers restorations on their bilateral maxillary anterior teeth.
- The selected teeth should be vital with absence of clinical signs and symptoms of periapical pathology.
- Patients having a normal occlusal relationship between upper and lower teeth (class I Angle classification).
- Patients capable of tolerating rubber dam applications.
- Patients willing to attend regular follow-up appointments.
Exclusion Criteria:
- Bad oral hygiene (Oral Hygiene Index Simplified >3).
- Non-vital teeth or endodontically treated teeth.
- Severe periodontal disease.
- Patients with para-functional habits (e.g., bruxism, attrition, wear facets).
- Dentin exposure more than 20% of the prepared surface for veneer.
- Prescence of smoking/vaping habits
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego)
|
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
|
|
Comparador activo: group II: 28 veneers will be done using milling technology (Cerasmart 270, GC)
|
A total of fifty-six anterior indirect veneers will be fabricated using 3D printing and milling technologies.
The veneers will be divided into two groups according to the technique of fabrication.
Group I: 28 veneers will be done using 3D printing technology (VarseoSmile TriniQ, Bego), and group II: 28 veneers will be done using milling technology (Cerasmart 270, GC).
Veneer restorations will be fabricated checked, and cemented, then will be evaluated using the modified FDI criteria at baseline, three months, six months, and one year.
Moreover, color stability and surface wear of the restorations will be evaluated in each follow-up session.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The functional properties of the examined veneer restorations
Periodo de tiempo: 1 year
|
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Functional properties: (F1) Fracture of material and retention.
(F2) Marginal adaptation.
(F3) Proximal contact point.
(F4) Form and contour.
(F5) Occlusion and wear.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), score 3: Clinically satisfactory (CS), score 4: Clinically unsatisfactory (CU), score 5: Clinically poor (PO).
|
1 year
|
|
The biological properties of the examined veneer restorations
Periodo de tiempo: 1 year
|
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the revised FDI evaluation criteria and scoring system, which indicates: Biological properties (B1) Caries at restoration margins.
(B2) Dental hard tissue defects at the restoration margin.
(B3) Postoperative hypersensitivity and pulpal status.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
|
1 year
|
|
The aesthetic properties of the examined veneers
Periodo de tiempo: 1 year
|
All veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, and 12 months, following the FDI evaluation criteria and scoring system, which indicates: Aesthetic properties: (A1) Surface luster and surface texture.
(A2) Marginal staining.
(A3) Color match.
Each evaluated property was scored according to the FDI criteria using the following clinical scores: Score 1: Clinically excellent/very good (VG), Score 2: Clinically good (CG), Score 3: Clinically satisfactory (CS), Score 4: Clinically unsatisfactory (CU), Score 5: Clinically poor (PO).
|
1 year
|
|
The color stability of the examined veneers
Periodo de tiempo: 1 year
|
All Veneers were assessed clinically at 1 week (baseline) and subsequently at 3, 6, 9, and 12 months using the vita easy shade spectrophotometer.
The CIEDE2000 formula will be used to measure the color change.
|
1 year
|
|
Wear resistance of the examined veneers
Periodo de tiempo: 1 year
|
All Veneers were scanned clinically using an intra oral scanner at 1 week (baseline) and subsequently at 3, 6, and 12 months.
The different scans were compared to baseline scan to assess the volume loss and accordingly the wear resistant.
|
1 year
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de mayo de 2025
Finalización primaria (Actual)
5 de agosto de 2026
Finalización del estudio (Actual)
5 de agosto de 2026
Fechas de registro del estudio
Enviado por primera vez
5 de agosto de 2026
Primero enviado que cumplió con los criterios de control de calidad
5 de agosto de 2026
Publicado por primera vez (Actual)
10 de agosto de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
12 de agosto de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
10 de agosto de 2026
Última verificación
1 de agosto de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- 9262109
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .